A novel efflux pump similar to Nor efflux pumps and designated as NorK was identified in 16 Staphylococcus aureus. It contributes to norfloxacin resistance and presents a high level of 17 expression in different strains. Its expression is not regulated by MgrA, unlike other genes of the 18 nor gene family, suggesting that NorK could be important in the absence of expression of other 19 nor genes. 20 21
3
Staphylococcus aureus is a major opportunistic bacterial pathogen responsible for a 22 variety of diseases (1). Its success in causing life-threatening infections is due to its considerable 23 production of toxins and ability to develop resistance to a wide spectrum of antibacterial 24 compounds (2, 3). Various systems have been developed by S. aureus to make it resistant to these 25 substances, such as the alteration of drug binding sites, drug inactivation and the involvement of 26 efflux pumps. 27 The term multidrug resistance (MDR) pumps refers to numerous efflux pumps that are 28 classified into two major groups: (i) ABC-type transporters, which utilize ATP hydrolysis to extrude 29 target drugs, and (ii) secondary multidrug transporters, which exploit proton and sodium 30 gradients as energy sources. Among this latter group, the major facilitator superfamily (MFS) has 31 been studied extensively in staphylococcal species. In S. aureus, the Nor protein family belongs 32 to the MFS and can extrude a broad range of antibiotic substances such as the fluroquinolones 33 (FQ), norfloxacin and ciprofloxacin. Four different pumps involved in FQ resistance have been 34 described previously (4-7). NorA and NorB are responsible for a relatively high-level of resistance 35 to hydrophobic quinolones, whereas NorC seems to be involved in a low-level of resistance (6). 36 The NorD substrates remain to be discovered. 37 Here, we report a new chromosomally encoded Nor protein called NorK, which is highly 38 expressed independently of MgrA regulation and involved in norfloxacin resistance.
39
Identification of a new putative efflux pump. In a previous study (Briaud et al., 2019) , we 40 identified 4 different nor related genes from RNA sequencing data, using S. aureus NCTC8325 as 41 a reference genome (GenBank CP000253). Three of them have already been described: norB 42 (SAOUHSC_01448), norC (SAOUHSC_00058) and norD (SAOUHSC_02762). The last gene 43 4 SAOUHSC_02740 was encoded for an unknown protein and annotated as a putative drug 44 transporter. The so-called norK gene is 1.401 nucleotides long ( Fig. S1 ) and encodes for a 45 hypothetical protein of 466 amino acids. This protein shares relatively high homology with NorB 46 (57% identity and 76% similarity) and NorC (59% identity and 74% similarity) but low homology 47 with the NorA and NorD pumps (16% identity and 34% similarity with NorA, 16% identity and 39% 48 similarity with NorD). A phylogenetic analysis was conducted on Nor proteins and major 49 chromosomically encoded MFS efflux pumps from S. aureus NCTC8325 using ClustalW alignment 50 and the Maximum Likelihood method. As depicted by the cluster formed by both proteins (Fig.1) , 51 NorK is closely related to NorB and NorC. ClustalW alignment of NorK with NorB and NorC 52 proteins revealed that highly conserved domains were shared (Fig.2) . Moreover, the NorK protein 53 presented 14 transmembrane domains predicted by the Phyre2 web portal (8), similar to those 54 observed in the NorB and NorC pumps. Together these data suggest that NorK belongs to the 55 same family as the Nor proteins previously described. To assess if this pump was widely 56 distributed among S. aureus, BLAST analysis on a large collection of genotypically diverse 57 bacteremia isolates (9) was performed. The results showed that 98% (123/126) harbor norK genes 58 (identity and coverage >90%). 59 The expression of norK genes was explored by RT-qPCR (protocol in supplementary data) on 5 60 different laboratory strains of S. aureus and compared to norA, B, C and D gene expressions. The 61 norK transcript was consistently detected in all the strains tested at a level similar to norA and 62 norD genes ( Fig. 3 and S2 ), supporting functionality. 63 MgrA can act as a repressor or an activator of norA, norB and norC genes (5-7) depending on the 64 RsbU strain background and as a result of its phosphorylation state (22). We thus explored norK 65 5 gene expression in the Newman wild-type (WT, rsbU+) and the Newman ∆mgrA strain (11). mgrA 66 deletion had no impact on norK expression while increased norA and norC and decreased norB 67 expression were observed as expected for a RsbU positive background ( Fig. 4) (10, 12) .
68
NorK efflux activity and involvement in antibiotic resistance. To assess the functionality of NorK, 69 thus its efflux activity, an overexpressing S. aureus strain was built (protocol in supplementary 70 data) and an ethidium bromide efflux assay was performed as previously described (13). The rate 71 of fluorescent loss in norK-overexpressing strains was significantly higher compared to the WT 72 strain (Fig. 5 ). Antibiotic efflux was tested by time-kill assay in the presence of a representative 73 anti-staphylococcal fluoroquinolone, norfloxacin, as previously described (14). Wild-type and 74 norK-overexpressing strains were cultivated for 8 hours in Mueller-Hinton broth supplemented 75 with norfloxacin at ½MIC (0.19µg/mL), MIC (0.38µg/mL) and 2MIC (0.76µg/mL). At 2, 4, 6 and 8 76 hours, bacteria were enumerated by plating on TSA. The survival rates of the norK-overexpressing 77 strain were significantly higher (between 0.5 log and 1 log CFU/ml) than those for the WT strain. 78 In conclusion, NorK is a new member of the nor gene family and contributes to S. aureus 79 norfloxacin resistance. NorK is widely distributed within S. aureus strains and its high level of 80 expression may point to an important role in antibiotic resistance and fitness during the 81 colonization of infectious niches. Moreover, the MgrA-independent regulation of norK indicates 82 that its expression could be induced even though other nor-regulated genes were not expressed. 83 Further studies will be necessary to explore the expression profiles of nor genes in different 84 conditions (e.g., antibiotic stresses, infectious niches). 
